Principal Financial Group Inc. Boosts Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)

Principal Financial Group Inc. boosted its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 4.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 132,099 shares of the medical instruments supplier's stock after buying an additional 5,162 shares during the period. Principal Financial Group Inc. owned 0.54% of ICU Medical worth $20,498,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Allworth Financial LP raised its holdings in shares of ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock valued at $36,000 after buying an additional 100 shares during the period. Venturi Wealth Management LLC lifted its position in shares of ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier's stock worth $59,000 after purchasing an additional 302 shares in the last quarter. Point72 Hong Kong Ltd purchased a new position in shares of ICU Medical in the third quarter valued at approximately $72,000. Coldstream Capital Management Inc. purchased a new position in shares of ICU Medical in the third quarter valued at approximately $227,000. Finally, Atria Investments Inc purchased a new stake in ICU Medical during the 3rd quarter worth approximately $228,000. Institutional investors and hedge funds own 96.10% of the company's stock.

Insider Activity

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 6.70% of the company's stock.

Remove Ads

ICU Medical Stock Down 2.3 %

NASDAQ:ICUI traded down $3.42 during trading hours on Friday, hitting $146.33. The company's stock had a trading volume of 487,114 shares, compared to its average volume of 208,914. The stock has a market capitalization of $3.58 billion, a P/E ratio of -32.02 and a beta of 0.63. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The stock has a fifty day moving average of $160.63 and a 200-day moving average of $166.09. ICU Medical, Inc. has a 52-week low of $93.36 and a 52-week high of $196.26.

Analysts Set New Price Targets

ICUI has been the subject of several recent research reports. KeyCorp raised their price target on shares of ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research report on Wednesday, November 13th. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price for the company in a report on Wednesday, December 11th. StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. Finally, Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $199.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.